Procter & Gamble (PG) Adjusts FY12, Q2 EPS Outlook Following Teva Partnership

November 3, 2011 9:16 AM EDT
The Procter & Gamble Company (NYSE: PG) updated previously announced all-in sales and earnings guidance for fiscal year 2012 following the creation of a new global partnership and joint venture (JV) in consumer health care that was announced earlier today. In addition, the Company included in its guidance the expected one-time gain from the upcoming Pringles transaction with Diamond Foods, Inc. and the cost of P&G’s incremental restructuring plans, both of which will be reported as non-core items.

P&G said it continues to expect sales growth of three percent to six percent for fiscal year 2012. The Company updated its fiscal year 2012 outlook for all-in GAAP earnings per share to a range of $4.52 to $4.83, an increase of $0.35 to $0.50 per share from the previous range of $4.17 to $4.33. P&G also updated its outlook for Core EPS to include earnings dilution from the exit of the Snacks business of zero to $0.02 per share in fiscal 2012 depending on the actual timing of the completion of the transaction. The Company now expects Core EPS in the range of $4.15 to $4.33, up five to 10 percent compared to prior year core earnings per share of $3.95. The Street is currently looking for $4.19.

The Company made no changes to top-line guidance for the December quarter. P&G said it now expects all-in earnings per share to be in the range of $1.00 to $1.11, which includes non-core restructuring spending of zero to $0.05 per share. Excluding the non-core restructuring costs, core earnings per share are forecast in the range of $1.05 to $1.11, consistent with previous guidance. The Street sees $1.09.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Guidance

Related Entities

Earnings